Magnetic microgels to guide bone and joint regrowth after amputation
Magnetic Microgels for Composite Musculoskeletal Tissue Regeneration
This project uses injectable magnetic microgels that release two growth proteins in sequence to encourage bone and joint regrowth for people with finger or limb amputations.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11332904 on NIH RePORTER |
What this research studies
Researchers are engineering tiny magnetic hydrogel particles (microgels) that each carry one of two bone- and joint-building proteins and can be given together as a single injection. An external magnet is used to separate the microgels in the limb so each region gets the right protein at the right time. The team will test this spatiotemporal delivery in the mouse digit model to see if it can drive coordinated bone elongation and joint regeneration without multiple surgeries. The work aims to create a more practical, minimally invasive approach that could one day be studied in people who have lost fingers or limbs.
Who could benefit from this research
Good fit: People with recent or past finger or limb amputations would be the ultimate candidates for future clinical testing, though the current work is preclinical in animals and not enrolling patients.
Not a fit: People without limb or finger loss, or those with medical conditions that prevent tissue healing (for example severe uncontrolled vascular disease or infection), are unlikely to benefit from this approach.
Why it matters
Potential benefit: If successful, this could enable biological restoration of missing bone and joints after amputation, reducing the need for repeated surgeries and improving function and quality of life.
How similar studies have performed: Previous animal studies showed that BMP2 and BMP9 can stimulate bone elongation and joint-like tissue in mouse digits, but using magnetic microgels for single-injection, timed control is a novel approach.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Qu, Feini — University of Washington
- Study coordinator: Qu, Feini
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.